Our US affiliation can provide services at a fraction of the cost, particularly with respect to Hatch-Waxman matters in the field of generic pharmaceuticals. We have experience in the following areas and can provide these services.
Our US affiliation can provide services at a fraction of the cost, particularly with respect to Hatch-Waxman matters in the field of generic pharmaceuticals. We have experience in the following areas and can provide these services.
FTUP can coordinate with our parent company for hiring attorneys for any patent-related litigations.
“Soft-Chew Tablet Pharmaceutical Formulations”, filed December 2016.
International Patent Application No. PCT/US2016/067443 US PATENT NO. 10,117,831 EPO National Stage Application No: 2016876888 |
“Abuse Deterrent Soft Chewable Drug Formulations”, filed February 2017.
International Patent Application No. PCT/US2017/019869 |